THIOXYLOSIDE DERIVATIVES AS ORALLY ACTIVE VENOUS ANTITHROMBOTICS
F. D. BELLAMY, V. BARBEROUSSE, Niall M.B. Martin et al. · European Journal of Medicinal Chemistry · 1995
Cited by 53 works. doi:10.1016/s0223-5234(23)00117-4
Authors
- F. D. BELLAMY
- V. BARBEROUSSE
- Niall M.B. Martin
- Philippe Masson
- Jean Millet
- Soth Samreth
- Christiane Sepulchre
- Jocelyne Theveniaux
- Derek Horton
References
- The anticoagulant effect of heparan sulfate and dermatan sulfate
- Stimulation of Synthesis of Free Chondroitin Sulfate Chains by β-D-Xylosides in Cultured Cells
- Regulation of chondroitin sulfate synthesis. Effect of beta-xylosides on synthesis of chondroitin sulfate proteoglycan, chondroitin sulfate chains, and core protein.
- Bleeding Time in Rats: A Comparison of Different Experimental Conditions
- Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure.
- Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis.
- A Randomised, Double-Blind, Placebo-Controlled Trial of Dermatan Sulphate for Prevention of Deep Vein Thrombosis in Hip Fracture
- Comparison of the haemorrhagic effects of porcine and bovine heparin in rabbits
- Control of chondroitin sulphate biosynthesis. β- d -Xylopyranosides as substrates for UDP-galactose: d -xylose transferase from embryonic-chicken cartilage
- Glycosylated derivatives of benzophenone, benzhydrol and benzhydril as potential venous antithrombotic agents